Neoplasm
2 competing products in clinical development for Neoplasm.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Clarithromycin | Eli Lilly | Phase 1 | Completed | 29 |
| CS-7017 | Daiichi Sankyo | Phase 1 | Completed | 29 |
2 competing products in clinical development for Neoplasm.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Clarithromycin | Eli Lilly | Phase 1 | Completed | 29 |
| CS-7017 | Daiichi Sankyo | Phase 1 | Completed | 29 |